NCT05488990 - Efficacy and Safety of Novel Formulations of Topical Calcipotriol in Patients With Mild to Moderate Plaque Psoriasis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 25, 2013

Primary Completion Date

June 17, 2013

Study Completion Date

June 17, 2013

Conditions

Psoriasis Vulgaris

Interventions

DRUG

AKVANO-Calcipotriol formulation 1

Novel lipid based formulation (AKVANO) type 1 containing Calcipotriol (50 μg/g)

DRUG

AKVANO-Calcipotriol formulation 2

Novel lipid based formulation (AKVANO) type 2 containing Calcipotriol (50 μg/g)

DRUG

AKVANO vehicle formulation 1

Novel lipid based formulation (AKVANO) vehicle 1

DRUG

AKVANO vehicle formulation 2

Novel lipid based formulation (AKVANO) vehicle 2

DRUG

Daivonex solution

Daivonex solution containing Calcipotriol (50 μg/g)

DRUG

Daivonex cream

Daivonex cream containing Calcipotriol (50 μg/g)

Trial Locations (1)

bioskin GmbH, Bergmannstrasse